Recurrent Ventricular Fibrillation Associated With Graves' Disease: A Case Report.

IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Case Reports in Cardiology Pub Date : 2026-06-28 eCollection Date: 2026-01-01 DOI:10.1155/cric/6567826
In Tae Moon, Sihun Kim, Sung Hun Park, You-Jeong Ki, Jung Yeon Chin
{"title":"Recurrent Ventricular Fibrillation Associated With Graves' Disease: A Case Report.","authors":"In Tae Moon, Sihun Kim, Sung Hun Park, You-Jeong Ki, Jung Yeon Chin","doi":"10.1155/cric/6567826","DOIUrl":null,"url":null,"abstract":"<p><p>Although tachyarrhythmias are associated with thyrotoxicosis, the association with ventricular fibrillation is unknown. This case reports a recurrent ventricular fibrillation with Graves' disease that was successfully treated with an implantable cardioverter defibrillator. A 33-year-old woman presented with ventricular fibrillation cardiac arrest. She was diagnosed with Graves' disease and was taking antithyroid drugs, but her hyperthyroidism was poorly controlled. The patient received intensive care unit care, including extracorporeal membrane oxygenator, ventilator, and renal replacement therapy. Implantable cardioverter defibrillator was implanted for the secondary prevention of ventricular fibrillation. Two months after the procedure, ventricular fibrillation recurred, and an implantable cardioverter defibrillator successfully prevented sudden cardiac death. She maintained a normal sinus rhythm and normal thyroid function after receiving radioactive iodine-131 therapy. Ventricular fibrillation is a rare but fatal manifestation in patients with hyperthyroidism. Implantable cardioverter defibrillator should be considered, especially in patients with poorly controlled hyperthyroidism, for the prevention of sudden cardiac death.</p>","PeriodicalId":51760,"journal":{"name":"Case Reports in Cardiology","volume":"2026 ","pages":"6567826"},"PeriodicalIF":0.5000,"publicationDate":"2026-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13311308/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/cric/6567826","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Although tachyarrhythmias are associated with thyrotoxicosis, the association with ventricular fibrillation is unknown. This case reports a recurrent ventricular fibrillation with Graves' disease that was successfully treated with an implantable cardioverter defibrillator. A 33-year-old woman presented with ventricular fibrillation cardiac arrest. She was diagnosed with Graves' disease and was taking antithyroid drugs, but her hyperthyroidism was poorly controlled. The patient received intensive care unit care, including extracorporeal membrane oxygenator, ventilator, and renal replacement therapy. Implantable cardioverter defibrillator was implanted for the secondary prevention of ventricular fibrillation. Two months after the procedure, ventricular fibrillation recurred, and an implantable cardioverter defibrillator successfully prevented sudden cardiac death. She maintained a normal sinus rhythm and normal thyroid function after receiving radioactive iodine-131 therapy. Ventricular fibrillation is a rare but fatal manifestation in patients with hyperthyroidism. Implantable cardioverter defibrillator should be considered, especially in patients with poorly controlled hyperthyroidism, for the prevention of sudden cardiac death.

复发性心室颤动伴格雷夫斯病1例
虽然快速性心律失常与甲状腺毒症有关,但与心室颤动的关系尚不清楚。本病例报告复发性心室颤动与格雷夫斯病,成功地治疗了植入式心律转复除颤器。一名33岁女性,因室性颤动心脏骤停。她被诊断出患有格雷夫斯病,正在服用抗甲状腺药物,但她的甲状腺功能亢进控制得很差。患者接受重症监护室护理,包括体外膜氧合机、呼吸机和肾脏替代治疗。植入式心律转复除颤器用于心室颤动的二级预防。手术后两个月,心室颤动复发,植入式心律转复除颤器成功预防了心源性猝死。接受放射性碘-131治疗后,窦性心律正常,甲状腺功能正常。心室纤颤是甲亢患者罕见但致命的表现。应考虑植入式心律转复除颤器,特别是控制不佳的甲亢患者,以预防心源性猝死。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Cardiology
Case Reports in Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
63
审稿时长
13 weeks
期刊介绍: Case Reports in Cardiology is a peer-reviewed, Open Access journal that publishes case reports and case series related to hypertension, arrhythmia, congestive heart failure, valvular heart disease, vascular disease, congenital heart disease and cardiomyopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书